{"count": 2, "results": [{"_id": "34793552", "pmid": 34793552, "pmcid": "PMC8601451", "title": "Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker", "journal": "PLoS One", "authors": ["Du XL", "Simpson LM", "Tandy BC", "Bettencourt JL", "Davis BR"], "date": "2021-11-18T00:00:00Z", "doi": "10.1371/journal.pone.0260107", "meta_date_publication": "2021", "meta_volume": "16", "meta_issue": "11", "meta_pages": "e0260107", "score": 50247.812, "text_hl": "Hispanics, those who used @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@ or @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in-trial, had @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, more education, and a history of @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@ had a significantly lower risk of having @<m>DISEASE_Gastrointestinal_Hemorrhage</m> @DISEASE_MESH:D006471 @@@GI bleeding@@@ than their counterparts. ", "citations": {"NLM": "Du XL, Simpson LM, Tandy BC, Bettencourt JL, Davis BR. Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker PLoS One. 2021;16(11):e0260107. PMID: 34793552", "BibTeX": "@article{34793552, title={Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker}, author={Du XL and Simpson LM and Tandy BC and Bettencourt JL and Davis BR}, journal={PLoS One}, volume={16}, number={11}, pages={e0260107}}"}}, {"_id": "24283598", "pmid": 24283598, "title": "Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT.", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Phillips W", "Piller LB", "Williamson JD", "Whittle J", "Jafri SZ", "Ford CE", "Einhorn PT", "Oparil S", "Furberg CD", "Grimm RH Jr", "Alderman MH", "Davis BR", "Probstfield JL", "ALLHAT Collaborative Research Group"], "date": "2013-11-01T00:00:00Z", "doi": "10.1111/jch.12180", "meta_date_publication": "2013 Nov", "meta_volume": "15", "meta_issue": "11", "meta_pages": "825-32", "score": 50052.83, "text_hl": "In-study use of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ prior to first @<m>DISEASE_Gastrointestinal_Hemorrhage</m> @DISEASE_MESH:D006471 @@@GI hemorrhage@@@ was related to a lower incidence of @<m>DISEASE_Gastrointestinal_Hemorrhage</m> @DISEASE_MESH:D006471 @@@GI bleeding@@@ (HR, 0.69; 95% CI, 0.57-0.83). ", "citations": {"NLM": "Phillips W, Piller LB, Williamson JD, Whittle J, Jafri SZ, Ford CE, Einhorn PT, Oparil S, Furberg CD, Grimm RH Jr, Alderman MH, Davis BR, Probstfield JL, ALLHAT Collaborative Research Group. Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT. J Clin Hypertens (Greenwich). 2013 Nov;15(11):825-32. PMID: 24283598", "BibTeX": "@article{24283598, title={Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT.}, author={Phillips W and Piller LB and Williamson JD and Whittle J and Jafri SZ and Ford CE and Einhorn PT and Oparil S and Furberg CD and Grimm RH Jr and Alderman MH and Davis BR and Probstfield JL and ALLHAT Collaborative Research Group}, journal={J Clin Hypertens (Greenwich)}, volume={15}, number={11}, pages={825-32}}"}}]}